191 related articles for article (PubMed ID: 27880847)
1. Activation of Both the Calpain and Ubiquitin-Proteasome Systems Contributes to Septic Cardiomyopathy through Dystrophin Loss/Disruption and mTOR Inhibition.
Freitas AC; Figueiredo MJ; Campos EC; Soave DF; Ramos SG; Tanowitz HB; Celes MR
PLoS One; 2016; 11(11):e0166839. PubMed ID: 27880847
[TBL] [Abstract][Full Text] [Related]
2. Disruption of calcium homeostasis in cardiomyocytes underlies cardiac structural and functional changes in severe sepsis.
Celes MR; Malvestio LM; Suadicani SO; Prado CM; Figueiredo MJ; Campos EC; Freitas AC; Spray DC; Tanowitz HB; da Silva JS; Rossi MA
PLoS One; 2013; 8(7):e68809. PubMed ID: 23935889
[TBL] [Abstract][Full Text] [Related]
3. Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy.
Campos EC; O'Connell JL; Malvestio LM; Romano MM; Ramos SG; Celes MR; Prado CM; Simões MV; Rossi MA
Eur J Pharmacol; 2011 Nov; 670(2-3):541-53. PubMed ID: 21946105
[TBL] [Abstract][Full Text] [Related]
4. Cardiomyocyte degeneration with calpain deficiency reveals a critical role in protein homeostasis.
Galvez AS; Diwan A; Odley AM; Hahn HS; Osinska H; Melendez JG; Robbins J; Lynch RA; Marreez Y; Dorn GW
Circ Res; 2007 Apr; 100(7):1071-8. PubMed ID: 17332428
[TBL] [Abstract][Full Text] [Related]
5. Effect of calpain and proteasome inhibition on Ca2+-dependent proteolysis and muscle histopathology in the mdx mouse.
Briguet A; Erb M; Courdier-Fruh I; Barzaghi P; Santos G; Herzner H; Lescop C; Siendt H; Henneboehle M; Weyermann P; Magyar JP; Dubach-Powell J; Metz G; Meier T
FASEB J; 2008 Dec; 22(12):4190-200. PubMed ID: 18728218
[TBL] [Abstract][Full Text] [Related]
6. Cooperation between proteolytic systems in cardiomyocyte recycling.
Yamaguchi O; Taneike M; Otsu K
Cardiovasc Res; 2012 Oct; 96(1):46-52. PubMed ID: 22843702
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in locomotor and respiratory muscles during experimental sepsis in mice.
Morel J; Palao JC; Castells J; Desgeorges M; Busso T; Molliex S; Jahnke V; Del Carmine P; Gondin J; Arnould D; Durieux AC; Freyssenet D
Sci Rep; 2017 Sep; 7(1):10866. PubMed ID: 28883493
[TBL] [Abstract][Full Text] [Related]
8. mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy.
Zhao J; Zhai B; Gygi SP; Goldberg AL
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15790-7. PubMed ID: 26669439
[TBL] [Abstract][Full Text] [Related]
9. Dystrophin involved in the susceptibility of slow muscles to hindlimb unloading via concomitant activation of TGF-β1/Smad3 signaling and ubiquitin-proteasome degradation in mice.
Zhang P; Li W; Liu H; Li J; Wang J; Li Y; Chen X; Yang Z; Fan M
Cell Biochem Biophys; 2014 Nov; 70(2):1057-67. PubMed ID: 24839113
[TBL] [Abstract][Full Text] [Related]
10. Impaired SIRT3 activity mediates cardiac dysfunction in endotoxemia by calpain-dependent disruption of ATP synthesis.
Koentges C; Cimolai MC; Pfeil K; Wolf D; Marchini T; Tarkhnishvili A; Hoffmann MM; Odening KE; Diehl P; von Zur Mühlen C; Alvarez S; Bode C; Zirlik A; Bugger H
J Mol Cell Cardiol; 2019 Aug; 133():138-147. PubMed ID: 31201798
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the calpain and ubiquitin-proteasome systems in a canine model of muscular dystrophy.
Wadosky KM; Li L; Rodríguez JE; Min JN; Bogan D; Gonzalez J; Patterson C; Kornegay JN; Willis M
Muscle Nerve; 2011 Oct; 44(4):553-62. PubMed ID: 21826685
[TBL] [Abstract][Full Text] [Related]
12. Disruption of sarcolemmal dystrophin and beta-dystroglycan may be a potential mechanism for myocardial dysfunction in severe sepsis.
Celes MR; Torres-Dueñas D; Malvestio LM; Blefari V; Campos EC; Ramos SG; Prado CM; Cunha FQ; Rossi MA
Lab Invest; 2010 Apr; 90(4):531-42. PubMed ID: 20142806
[TBL] [Abstract][Full Text] [Related]
13. Calpain inhibitors improve myocardial dysfunction and inflammation induced by endotoxin in rats.
Tissier S; Lancel S; Marechal X; Mordon S; Depontieu F; Scherpereel A; Chopin C; Neviere R
Shock; 2004 Apr; 21(4):352-7. PubMed ID: 15179136
[TBL] [Abstract][Full Text] [Related]
14. Calpain activation causes a proteasome-dependent increase in protein degradation and inhibits the Akt signalling pathway in rat diaphragm muscle.
Smith IJ; Dodd SL
Exp Physiol; 2007 May; 92(3):561-73. PubMed ID: 17272355
[TBL] [Abstract][Full Text] [Related]
15. Increased sarcolemmal permeability as an early event in experimental septic cardiomyopathy: a potential role for oxidative damage to lipids and proteins.
Celes MR; Torres-Dueñas D; Prado CM; Campos EC; Moreira JE; Cunha FQ; Rossi MA
Shock; 2010 Mar; 33(3):322-31. PubMed ID: 20160610
[TBL] [Abstract][Full Text] [Related]
16. Build it up-Tear it down: protein quality control in the cardiac sarcomere.
Willis MS; Schisler JC; Portbury AL; Patterson C
Cardiovasc Res; 2009 Feb; 81(3):439-48. PubMed ID: 18974044
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles.
Tawa NE; Odessey R; Goldberg AL
J Clin Invest; 1997 Jul; 100(1):197-203. PubMed ID: 9202072
[TBL] [Abstract][Full Text] [Related]
18. Calpain mediates cardiac troponin degradation and contractile dysfunction in atrial fibrillation.
Ke L; Qi XY; Dijkhuis AJ; Chartier D; Nattel S; Henning RH; Kampinga HH; Brundel BJ
J Mol Cell Cardiol; 2008 Nov; 45(5):685-93. PubMed ID: 18823990
[TBL] [Abstract][Full Text] [Related]
19. Sepsis stimulates release of myofilaments in skeletal muscle by a calcium-dependent mechanism.
Williams AB; Decourten-Myers GM; Fischer JE; Luo G; Sun X; Hasselgren PO
FASEB J; 1999 Aug; 13(11):1435-43. PubMed ID: 10428767
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of the ubiquitin-proteasome proteolysis system by amino acids and insulin involves the adenosine monophosphate-activated protein kinase and mammalian target of rapamycin pathways in rat hepatocytes.
Chotechuang N; Azzout-Marniche D; Bos C; Chaumontet C; Gaudichon C; Tomé D
Amino Acids; 2011 Jul; 41(2):457-68. PubMed ID: 20957397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
